- Home
- STIM vs ACIU Comparison
STIM vs ACIU Comparison
Compare STIM & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STIM
- ACIU
- Stock Information
- Founded
- STIM 2003
- ACIU 2003
- Country
- STIM United States
- ACIU Switzerland
- Employees
- STIM N/A
- ACIU N/A
- Industry
- STIM Medical/Dental Instruments
- ACIU Biotechnology: Pharmaceutical Preparations
- Sector
- STIM Health Care
- ACIU Health Care
- Exchange
- STIM Nasdaq
- ACIU Nasdaq
- Market Cap
- STIM 224.8M
- ACIU 213.3M
- IPO Year
- STIM 2018
- ACIU 2016
- Fundamental
- Price
- STIM $2.73
- ACIU $2.94
- Analyst Decision
- STIM Strong Buy
- ACIU Strong Buy
- Analyst Count
- STIM 2
- ACIU 2
- Target Price
- STIM $7.00
- ACIU $10.00
- AVG Volume (30 Days)
- STIM 1.1M
- ACIU 343.9K
- Earning Date
- STIM 11-11-2025
- ACIU 11-04-2025
- Dividend Yield
- STIM N/A
- ACIU N/A
- EPS Growth
- STIM N/A
- ACIU N/A
- EPS
- STIM N/A
- ACIU N/A
- Revenue
- STIM $111,106,000.00
- ACIU $36,362,036.00
- Revenue This Year
- STIM $105.70
- ACIU N/A
- Revenue Next Year
- STIM $11.77
- ACIU $1,022.98
- P/E Ratio
- STIM N/A
- ACIU N/A
- Revenue Growth
- STIM 54.17
- ACIU 86.71
- 52 Week Low
- STIM $0.52
- ACIU $1.43
- 52 Week High
- STIM $5.92
- ACIU $3.99
- Technical
- Relative Strength Index (RSI)
- STIM 40.26
- ACIU 49.27
- Support Level
- STIM $2.65
- ACIU $2.89
- Resistance Level
- STIM $3.21
- ACIU $3.21
- Average True Range (ATR)
- STIM 0.20
- ACIU 0.33
- MACD
- STIM 0.02
- ACIU -0.09
- Stochastic Oscillator
- STIM 12.70
- ACIU 8.75
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.